
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a…
View original source — South China Morning Post ↗



